5Mon

What will

•

4

•

ThemenmitKopf@topicswithhead

5Mon

Good buy

•

1

•

spatzis@spatzis

5Mon

@topicswithhead Why do you think that? Kind regards

••

ThemenmitKopf@topicswithhead

5Mon

@dividend_dynamo_824 you don't know yourself why you are in or how. Interesting sector in which you are also marketing with an interesting concept. Biosimmilar is simply a highly lucrative area if you do it right

••

spatzis@spatzis

5Mon

@topicswithhead 😀 I already know why I'm in. I was just interested in your opinion ;)

••

ThemenmitKopf@topicswithhead

5Mon

@dividend_dynamo_824 is just very lucrative and in principle much simpler than the other concepts, which is why you hopefully also get better and safer margins. But there are also other interesting providers, such as Sandoz. Why did you go in?

••

spatzis@spatzis

5Mon

@topicswithhead An important approval for a biosimilar candidate is expected in mid-January. So it could continue to go up. Besides, you already said that the sector is simply very interesting 👍🏼

••

Novius@Novius

2Mon

Hmmh, now the share price looks different. What do the people invested here think?

••

spatzis@spatzis

2Mon

Got out with a profit a few weeks ago. Fortunately

••

ThemenmitKopf@topicswithhead

2Mon

@Novius stay invested Little has changed in my thesis, regardless of that I can't tell you now whether it's a bargain or not. It seems that more companies are entering the market than planned. Probably all want to cut profits

••

Novius@Novius

2Mon

@topicswithhead am currently at -52%. I'm thinking about buying more "cheaply"

••

ThemenmitKopf@topicswithhead

2Mon

@Novius It depends on how much they make up of your portfolio. I have too much Germany and want to halve a few stocks before I buy more. If it is still at the price, I would buy a small position. However, I also have Amgen as a biosimmilar candidate and I'm also looking at Sandoz.

••

spatzis@spatzis

4Mon

Will be something

••

spatzis@spatzis

2Mon

📉

••